Gastrointestinal Motility Disorders

Mayo Clinic Gastroenterology and Hepatology Board Review, Third Edition

Volumn , Issue , 2008, Pages 97-114

  Camilleri, Michael ^a,b   Locke, G Richard ^a,b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862297773     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14432-12     Document Type: Chapter

References (19)

1. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15, 000 adults. Arch Intern Med. 2001;161:1989-96.
2. Camilleri M. Clinical practice: diabetic gastroparesis. N Engl J Med. 2007;356:820-9.
3. Camilleri M. Enteric nervous system disorders:genetic and molecular insights for the neurogastroenterologist. Neurogastroenterol Motil. 2001;13:277-95.
4. Camilleri M. Functional dyspepsia: mechanisms of symptom generation and appropriate management of patients. Gastroenterol Clin North Am. 2007; 36:649-64.
5. Coulie B, Camilleri M. Intestinal pseudo-obstruction. Annu Rev Med. 1999;50:37-55.
6. Delaney BC, Moayyedi P, Forman D. Initial management strategies for dyspepsia. Cochrane Database Syst Rev. 2003;(2):CD001961. Update in: Cochrane Database Syst Rev. 2005;(4):CD001961.
7. Di Lorenzo C. Pseudo-obstruction: current approaches. Gastroenterology. 1999;116:980-7.
8. Fischler B, Tack J, De Gucht V, Shkedy ZI, Persoons P, Broekaert D, et al. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology. 2003;124:903-10.
9. Johnsen R, Bernersen B, Straume B, Førde OH, Bostad L, Burhol PG. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ. 1991; 302:749-52.
10. Karamanolis G, Caenepeel P, Arts J, Tack J. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology. 2006;130:296-303.
11. Locke GR 3rd. Prevalence, incidence and natural history of dyspepsia and functional dyspepsia. Baillieres Clin Gastroenterol. 1998;12:435-42.
12. Maleki D, Locke GR 3rd, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000;160:2808-16.
13. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2005;(1):CD002096. Update in:Cochrane Database Syst Rev. 2006;(2):CD002096.
14. Pachnis V, Durbec P, Taraviras S, Grigoriou M, Natarajan D. Role of the RET signal transduction pathway in development of the mammalian enteric nervous system. Am J Physiol. 1998;275:G183-6.
15. Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001;24:371-81.
16. Rhee PL, Kim YH, Son HJ, Kim JJ, Koh KC, Paik SW, et al. Lack of association of Helicobacter pylori infection with gastric hypersensitivity or delayed gastric emptying in functional dyspepsia. Am J Gastroenterol. 1999; 94:3165-9.
17. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466-79.
18. Talley NJ, Vakil N, Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005;100:2324-37.
19. Wood JD, Alpers DH, Andrews PL. Fundamentals of neurogastroenterology. Gut. 1999; 45 Suppl 2:II-6-II-16.